The FDP assumes that a public vaccination of Merkel and Steinmeier would promote confidence.
Meanwhile, Karl Lauterbach is being vaccinated with the Astrazeneca vaccine.
Berlin - The FDP * has called for a quick vaccination * from Federal President Frank-Walter Steinmeier and Chancellor Angela Merkel * against the corona virus *.
This could be used to attract trust in the vaccinations, said deputy group leader Michael Theurer of the
picture.
A public vaccination of the Federal President and the Chancellor would be a "very positive signal" for the vaccination campaign, emphasized the FDP politician.
Such an action would, in his words, “build trust”.
There is currently a discussion about the reliability of the corona vaccine * from the British-Swedish manufacturer Astrazeneca *.
Federal Minister of Health Jens Spahn had advertised the drug on Wednesday against the background of the acceptance problems of this vaccine.
He called it "safe and effective".
FDP calls for Merkel and Steinmeier to be vaccinated: Trust in Astrazeneca should be strengthened
According to studies, the Astrazeneca vaccine is less effective than the other two corona vaccines from Biontech / Pfizer * and Moderna that have so far been approved in the EU.
According to its manufacturer, the Astrazeneca agent reliably protects against particularly severe disease processes *.
Meanwhile, SPD * health expert Karl Lauterbach * has announced that he will be vaccinated with the Astrazeneca vaccine at the end of next week.
Lauterbach then works as a vaccination doctor in a Leverkusen vaccination center *.
"Like all members of the vaccination center, I will of course be vaccinated with Astrazeneca," said the doctor and member of the Bundestag the
Tagesspiegel
.
"We want to make a clear commitment to Astrazeneca, it is a safe and good vaccine."
Lauterbach can be vaccinated with Astrazeneca - SPD health expert makes an unusual proposal
Despite the widespread skepticism in connection with the Astrazeneca vaccine, Lauterbach spoke out against changing the sequence of vaccinations or only injecting doses that were not used immediately into volunteers.
“That would mean that the largest risk groups, including doctors and nurses under 65, are at risk for a longer period of time.” The recommendation of the Standing Vaccination Commission to only use this vaccine for under 65-year-olds “has obviously damaged the vaccine, many see it unjustifiably as a second-class vaccine *, ”criticized Lauterbach.
In order to make faster progress with the vaccinations in view of the coronavirus mutations * and a possible third wave * and to protect the elderly more quickly, Lauterbach made an unusual suggestion: “From the 14th day after the first dose of Biontech / Pfizer and Moderna, the Protection at around 92 percent.
It is extremely unlikely that protection will drop in the weeks thereafter.
One could therefore consider starting the second dose after six or twelve weeks. ”This would then protect many more people in the greatest risk groups and could save thousands of lives in Germany.
Video: FDP calls on Merkel and Steinmeier for corona vaccination
The vector-based Astrazeneca agent is an important building block in the EU's vaccination strategy because it is comparatively cheap and has less stringent requirements in terms of transport and storage than the mRNA vaccines from Biontech / Pfizer and Moderna.
This is crucial for the path towards vaccinations in medical practices.
It is about millions of doses that will soon be administered in Germany - for example to younger people with relevant previous illnesses and for certain professional groups with an increased risk of infection.
(dpa / AFP / fmü)
* Merkur.de is part of the nationwide Ippen digital editorial network.